Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-30

FDA Approved: FINGOLIMOD — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for fingolimod hydrochloride (Fingolimod) submitted by Ascend Laboratories, LLC under ANDA208004.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE)